Gallstone disease differential diagnosis: Difference between revisions
m Bot: Removing from Primary care |
|||
(15 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Gallstone_disease]] | |||
{{CMG}}; {{AE}} {{HM}} | {{CMG}}; {{AE}} {{HM}} | ||
==Overview== | ==Overview== | ||
Gallstone disease must be differentiated from other diseases that cause | Gallstone disease must be differentiated from other diseases that cause right upper quadrant pain including [[Gastroesophageal reflux disease|gastroesophageal reflux disorder]], [[peptic ulcer|peptic ulcer disease]],[[hepatitis]],[[sphincter of Oddi dysfunction]],[[appendicitis]], bile duct stricture, [[chronic pancreatitis]], [[irritable bowel syndrome]], [[coronary heart disease|ischemic heart disease]], [[pyelonephritis]], [[ureter|ureteral]] calculi and complications of gallstone disease include: [[cholecystitis|acute cholecystitis]], [[choledocholithiasis]], [[acute pancreatitis]], and acute [[cholangitis]]. | ||
==Differentiating Gallstone disease from other Diseases== | ==Differentiating Gallstone disease from other Diseases== | ||
* Gallstone disease can manifest in a variety of clinical forms. | |||
* The presence of biliary colic is an important diagnostic feature to distinguish between gallstones and non-biliary stone disorders. | |||
'''However, it is important to note that biliary colic concomitant in patients with other biliary disorders such as [[Cholecystitis|acute cholecystitis]], [[choledocholithiasis]], [[sphincter of Oddi dysfunction]], and functional gallbladder disorder.''' | * Patients who present with biliary colic are more likely to have gallstones detected on imaging. <ref name="pmid7638565">{{cite journal |vauthors=Kraag N, Thijs C, Knipschild P |title=Dyspepsia--how noisy are gallstones? A meta-analysis of epidemiologic studies of biliary pain, dyspeptic symptoms, and food intolerance |journal=Scand. J. Gastroenterol. |volume=30 |issue=5 |pages=411–21 |year=1995 |pmid=7638565 |doi= |url=}}</ref> | ||
* '''However, it is important to note that biliary colic can be concomitant in patients with other biliary disorders such as [[Cholecystitis|acute cholecystitis]], [[choledocholithiasis]], [[sphincter of Oddi dysfunction]], and functional [[gallbladder]] disorder.'''<ref name="pmid16844493">{{cite journal |vauthors=Portincasa P, Moschetta A, Palasciano G |title=Cholesterol gallstone disease |journal=Lancet |volume=368 |issue=9531 |pages=230–9 |year=2006 |pmid=16844493 |doi=10.1016/S0140-6736(06)69044-2 |url=}}</ref><ref name="pmid19524793">{{cite journal |vauthors=Center SA |title=Diseases of the gallbladder and biliary tree |journal=Vet. Clin. North Am. Small Anim. Pract. |volume=39 |issue=3 |pages=543–98 |year=2009 |pmid=19524793 |doi=10.1016/j.cvsm.2009.01.004 |url=}}</ref> | |||
==Differential diagnosis== | ==Differential diagnosis== | ||
The differential diagnosis of diseases presenting with [[abdominal pain]], [[fever]] and [[jaundice]] is discussed below. | |||
<span style="font-size:85%">'''Abbreviations:''' | |||
'''[[RUQ]]'''= Right upper quadrant of the abdomen, '''LUQ'''= Left upper quadrant, '''LLQ'''= Left lower quadrant, '''RLQ'''= Right lower quadrant, '''LFT'''= [[Liver function test]], SIRS= [[Systemic inflammatory response syndrome]], '''[[ERCP]]'''= [[Endoscopic retrograde cholangiopancreatography]], '''IV'''= Intravenous, '''N'''= Normal, '''AMA'''= [[Antimitochondrial antibodies|Anti mitochondrial antibodies]], '''[[LDH]]'''= [[Lactate dehydrogenase]], '''GI'''= [[Gastrointestinal]], '''CXR'''= Chest X ray, '''IgA'''= [[Immunoglobulin A]], '''IgG'''= [[Immunoglobulin G]], '''IgM'''= [[Immunoglobulin M]], '''CT'''= [[Computed tomography]], '''[[PMN]]'''= Polymorphonuclear cells, '''[[ESR]]'''= [[Erythrocyte sedimentation rate]], '''[[CRP]]'''= [[C-reactive protein]], TS= [[Transferrin saturation]], SF= Serum [[Ferritin]], SMA= [[Superior mesenteric artery]], SMV= [[Superior mesenteric vein]], ECG= [[Electrocardiogram]]</span> | |||
<small> | <small> | ||
{| align="center" | {| align="center" | ||
|- | |- | ||
Line 65: | Line 48: | ||
! colspan="1" rowspan="15" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Inflammatory causes | ! colspan="1" rowspan="15" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Inflammatory causes | ||
! rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Pancreato-biliary disorders | ! rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Pancreato-biliary disorders | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Acute suppurative cholangitis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Acute suppurative [[cholangitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[RUQ]] | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[RUQ]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 75: | Line 58: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Abnormal [[LFT]] | * Abnormal [[LFT]] | ||
* WBC >10,000 | * [[WBC]] >10,000 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[biliary]] dilatation/stents/tumor | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[biliary]] [[dilatation]]/[[stents]]/[[tumor]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Septic shock occurs with features of [[SIRS]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Septic shock]] occurs with features of [[SIRS]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Cholangitis|Acute cholangitis]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Cholangitis|Acute cholangitis]] | ||
Line 92: | Line 75: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Abnormal [[LFT]] | * Abnormal [[LFT]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[biliary]] dilatation/stents/tumor | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[biliary]] [[dilatation]]/[[stents]]/[[tumor]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Biliary drainage ([[Endoscopic retrograde cholangiopancreatography|ERCP]]) + IV antibiotics | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Biliary]] drainage ([[Endoscopic retrograde cholangiopancreatography|ERCP]]) + IV [[antibiotics]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Acute cholecystitis|Acute cholecystitis]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Acute cholecystitis|Acute cholecystitis]] | ||
Line 108: | Line 91: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Hyperbilirubinemia]] | * [[Hyperbilirubinemia]] | ||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows gallstone and evidence of inflammation | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows gallstone and evidence of [[inflammation]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Murphy's sign|Murphy’s sign]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Murphy's sign|Murphy’s sign]] | ||
|- | |- | ||
Line 125: | Line 108: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Increased [[amylase]] / [[lipase]] | * Increased [[amylase]] / [[lipase]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Ultrasound shows evidence of [[inflammation]] | * [[Ultrasound]] shows evidence of [[inflammation]] | ||
* CT scan shows severity of pancreatitis | * [[CT scan]] shows severity of [[pancreatitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Pain radiation to back | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Pain]] radiation to back | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Primary sclerosing cholangitis]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Primary sclerosing cholangitis]] | ||
Line 143: | Line 126: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Increased liver enzymes | * Increased [[liver enzymes]] | ||
* Increased [[IgM]], [[IgG]]4 | * Increased [[IgM]], [[IgG]]4 | ||
* [[Anti-neutrophil cytoplasmic antibody]] ([[p-ANCA]]) | * [[Anti-neutrophil cytoplasmic antibody]] ([[p-ANCA]]) | ||
Line 151: | Line 134: | ||
* [[Anti-smooth muscle antibody]] (Anti-Sm) | * [[Anti-smooth muscle antibody]] (Anti-Sm) | ||
* Anti-endothelial antibody | * Anti-endothelial antibody | ||
* Anti-cardiolipin antibody | * [[Anticardiolipin antibody|Anti-cardiolipin antibody]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |ERCP and MRCP shows | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Endoscopic retrograde cholangiopancreatography|ERCP]] and [[Magnetic resonance cholangiopancreatography|MRCP]] shows | ||
* Multiple segmental [[strictures]] | * Multiple segmental [[strictures]] | ||
* Mural irregularities | * Mural irregularities | ||
* [[Biliary]] | * [[Biliary]] [[dilatation]] and [[diverticula]] | ||
* Distortion of biliary tree | * Distortion of [[biliary tree]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |The risk of [[cholangiocarcinoma]] in patients with primary sclerosing cholangitis is 400 times higher than the risk in the general population. | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |The risk of [[cholangiocarcinoma]] in patients with [[primary sclerosing cholangitis]] is 400 times higher than the risk in the general population. | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cholelithiasis]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cholelithiasis]] | ||
Line 169: | Line 152: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal to hyperactive for dislodged stone | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[gallstone]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[gallstone]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Fatty food intolerance | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Fatty food intolerance | ||
|- | |- | ||
Line 186: | Line 169: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hyperactive/hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* WBC> 10,000 | * [[WBC]]> 10,000 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Air under [[diaphragm]] in upright [[CXR]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Air under [[diaphragm]] in upright [[CXR]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hamman's sign]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hamman's sign]] | ||
Line 203: | Line 186: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal/ Hyperactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Anti-neutrophil cytoplasmic antibody]] ([[P-ANCA]]) in [[Ulcerative colitis]] | * [[Anti-neutrophil cytoplasmic antibody]] ([[P-ANCA]]) in [[Ulcerative colitis]] | ||
Line 209: | Line 192: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[String sign]] on [[abdominal x-ray]] in [[Crohn's disease]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[String sign]] on [[abdominal x-ray]] in [[Crohn's disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Extra intestinal findings: | Extra [[Intestine|intestinal]] findings: | ||
* [[Uveitis]] | * [[Uveitis]] | ||
* [[Arthritis]] | * [[Arthritis]] | ||
Line 223: | Line 206: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Thrombocytopenia]] | * [[Thrombocytopenia]] | ||
Line 249: | Line 232: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in Hep A and E | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[Hepatitis|Hep A]] and [[Hepatitis|Hep E]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in fulminant hepatitis | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in fulminant [[Hepatitis|hepatitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +in acute | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +in acute | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Abnormal LFTs | * Abnormal [[LFTs]] | ||
* Viral serology | * [[Viral]] [[serology]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hep A and E have fecoral route of transmission and Hep B and C transmits via blood transfusion and sexual contact. | * [[Ultrasound]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hepatitis|Hep A]]and [[Hepatitis|Hep E]] have fecoral route of transmission and [[Hepatitis|Hep B]] and [[Hepatitis|Hep C]] transmits via [[blood transfusion]] and [[sexual contact]]. | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Liver mass|Liver masses]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Liver mass|Liver masses]] | ||
Line 271: | Line 255: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[Liver abscess]] | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[Liver abscess]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[Liver abscess]] | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[Liver abscess]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* [[CBC]] | |||
* [[LFTs]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* | * [[Ultrasound]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- | ||
Line 290: | Line 275: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal/hypoactive | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal/hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* CBC | * [[CBC]] | ||
* Blood cultures | * [[Blood cultures]] | ||
* Abnormal [[Liver function test|liver function tests]] | * Abnormal [[Liver function test|liver function tests]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* | * [[Ultrasound]] | ||
* CT | * [[CT]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- | ||
Line 315: | Line 300: | ||
* Abnormal [[Liver function test|liver function tests]] | * Abnormal [[Liver function test|liver function tests]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* | * [[Ultrasound]] | ||
* CT | * [[CT]] | ||
* Liver biopsy | * [[Liver biopsy]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Other symptoms: | Other symptoms: | ||
Line 332: | Line 317: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in liver failure leading to varices | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[liver failure]] leading to [[varices]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Elevated [[Aspartate aminotransferase|serum aspartate aminotransferase]] and [[alanine aminotransferase]] levels may be more than five times the upper limit of the normal range. | *Elevated [[Aspartate aminotransferase|serum aspartate aminotransferase]] and [[alanine aminotransferase]] levels may be more than five times the upper limit of the normal range. | ||
*Elevated serum [[alkaline phosphatase]] and [[Bilirubin|bilirubin levels]], decreased [[Albumin|serum albumin level]]. | *Elevated serum [[alkaline phosphatase]] and [[Bilirubin|bilirubin levels]], decreased [[Albumin|serum albumin level]]. | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Findings on [[CT scan]] suggestive of [[Budd-Chiari syndrome]] include: | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Findings on [[CT scan]] suggestive of Budd-Chiari syndrome include: | |||
*Early enhancement of the [[caudate lobe]] and [[central liver]] around the [[Inferior vena cavae|inferior vena cava]] | *Early enhancement of the [[caudate lobe]] and [[central liver]] around the [[Inferior vena cavae|inferior vena cava]] | ||
*Delayed enhancement of the peripheral [[liver]] with accompanying central low density (flip-flop appearance) | *Delayed enhancement of the peripheral [[liver]] with accompanying central low density (flip-flop appearance) | ||
*Peripheral zones of the [[liver]] show reversed [[portal]] [[venous]] [[blood flow]] | *Peripheral zones of the [[liver]] show reversed [[portal]] [[venous]] [[blood flow]] | ||
*In the [[chronic]] phase, there is [[caudate lobe]] enlargement and [[atrophy]] of the [[Liver|peripheral liver]] in affected areas | *In the [[chronic]] phase, there is [[caudate lobe]] enlargement and [[atrophy]] of the [[Liver|peripheral liver]] in affected areas | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ascitic tap|Ascitic fluid examination]] shows: | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ascitic tap|Ascitic fluid examination]] shows: | ||
*[[Total protein]] more than 2.5 g per deciliter | *[[Total protein]] more than 2.5 g per deciliter | ||
Line 358: | Line 339: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in cirrhotic patients | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[cirrhotic]] patients | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
Line 364: | Line 345: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Ascitic fluid [[PMN]]>250 cells/mm<small>³</small> | * Ascitic fluid [[PMN]]>250 cells/mm<small>³</small> | ||
* Culture: Positive for single organism | * Culture: Positive for single organism | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound for evaluation of liver cirrhosis | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] for evaluation of [[liver cirrhosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- | ||
Line 375: | Line 356: | ||
|} | |} | ||
</small> | </small> | ||
To review a differential diagnosis for abdominal pain, [[Abdominal pain differential diagnosis|click here]] | To review a differential diagnosis for abdominal pain, [[Abdominal pain differential diagnosis|click here]] | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
Latest revision as of 21:48, 29 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Gallstone disease must be differentiated from other diseases that cause right upper quadrant pain including gastroesophageal reflux disorder, peptic ulcer disease,hepatitis,sphincter of Oddi dysfunction,appendicitis, bile duct stricture, chronic pancreatitis, irritable bowel syndrome, ischemic heart disease, pyelonephritis, ureteral calculi and complications of gallstone disease include: acute cholecystitis, choledocholithiasis, acute pancreatitis, and acute cholangitis.
Differentiating Gallstone disease from other Diseases
- Gallstone disease can manifest in a variety of clinical forms.
- The presence of biliary colic is an important diagnostic feature to distinguish between gallstones and non-biliary stone disorders.
- Patients who present with biliary colic are more likely to have gallstones detected on imaging. [1]
- However, it is important to note that biliary colic can be concomitant in patients with other biliary disorders such as acute cholecystitis, choledocholithiasis, sphincter of Oddi dysfunction, and functional gallbladder disorder.[2][3]
Differential diagnosis
The differential diagnosis of diseases presenting with abdominal pain, fever and jaundice is discussed below.
Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram
|
To review a differential diagnosis for abdominal pain, click here
References
- ↑ Kraag N, Thijs C, Knipschild P (1995). "Dyspepsia--how noisy are gallstones? A meta-analysis of epidemiologic studies of biliary pain, dyspeptic symptoms, and food intolerance". Scand. J. Gastroenterol. 30 (5): 411–21. PMID 7638565.
- ↑ Portincasa P, Moschetta A, Palasciano G (2006). "Cholesterol gallstone disease". Lancet. 368 (9531): 230–9. doi:10.1016/S0140-6736(06)69044-2. PMID 16844493.
- ↑ Center SA (2009). "Diseases of the gallbladder and biliary tree". Vet. Clin. North Am. Small Anim. Pract. 39 (3): 543–98. doi:10.1016/j.cvsm.2009.01.004. PMID 19524793.